Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Liquidia Technologies Inc (LQDA)

Liquidia Technologies Inc (LQDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 156,897
  • Shares Outstanding, K 28,372
  • Annual Sales, $ 8,070 K
  • Annual Income, $ -47,580 K
  • 60-Month Beta 0.82
  • Price/Sales 18.84
  • Price/Cash Flow N/A
  • Price/Book 6.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.39
  • Number of Estimates 1
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.32
  • Growth Rate Est. (year over year) -21.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.18 +6.18%
on 07/30/20
8.39 -34.45%
on 07/06/20
-2.29 (-29.40%)
since 07/02/20
3-Month
5.01 +9.78%
on 05/04/20
12.10 -54.55%
on 06/25/20
+0.37 (+7.21%)
since 05/01/20
52-Week
2.65 +107.55%
on 12/17/19
12.10 -54.55%
on 06/25/20
-0.85 (-13.39%)
since 08/02/19

Most Recent Stories

More News
Liquidia to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020

Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT(R) technology,...

LQDA : 5.45 (-1.45%)
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso Patent

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT(R) technology,...

UTHR : 115.43 (+3.55%)
LQDA : 5.45 (-1.45%)
SHAREHOLDER ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration,...

WLTW : 210.26 (+0.12%)
ADSW : 30.17 (+0.03%)
LQDA : 5.45 (-1.45%)
Liquidia Announces Closing of Public Offering of Common Stock

Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT technology, announced...

LQDA : 5.45 (-1.45%)
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT(R) technology,...

UTHR : 115.43 (+3.55%)
LQDA : 5.45 (-1.45%)
Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne

Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne

CALX : 21.00 (+2.39%)
NERV : 3.49 (+1.15%)
XONE : 9.05 (+3.31%)
ATXI : 10.30 (+1.68%)
LQDA : 5.45 (-1.45%)
5 Stocks With Recent Price Strength to Tap Wall Street Rally

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

CALX : 21.00 (+2.39%)
NERV : 3.49 (+1.15%)
XONE : 9.05 (+3.31%)
ATXI : 10.30 (+1.68%)
LQDA : 5.45 (-1.45%)
Liquidia to Present at the Jefferies Virtual Healthcare Conference

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT technology,...

LQDA : 5.45 (-1.45%)
Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?

Liquidia Technologies (LQDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

LQDA : 5.45 (-1.45%)
Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer

Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT technology,...

LQDA : 5.45 (-1.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade LQDA with:

Business Summary

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of...

See More

Key Turning Points

2nd Resistance Point 5.82
1st Resistance Point 5.68
Last Price 5.45
1st Support Level 5.35
2nd Support Level 5.16

See More

52-Week High 12.10
Fibonacci 61.8% 8.49
Fibonacci 50% 7.38
Fibonacci 38.2% 6.26
Last Price 5.45
52-Week Low 2.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar